Thromboangiitis Obliterans

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2017-04-07
Clinical Trial Update: A Clinical Trial to Study the Efficacy and Safety of Stempeucel® in Patients With CLI Due to Buergers Disease [Phase 2]
The Phase 2 trial evaluating Stempeucel for critical limb ischemia due to Buerger's disease has been withdrawn.